logo

Biomarin Pharmaceutical Inc. (BMRN)



Trade BMRN now with
  Date
  Headline
2/26/2019 7:43:48 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q2 20 Estimate To 0.07 From 0.27
2/26/2019 7:43:35 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q1 20 Estimate To 0.01 From 0.20
2/26/2019 7:43:15 AM Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) FY19 Estimate To -0.46 From 0.41
2/26/2019 7:42:47 AM Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) Q4 19 Estimate To -0.01 From 0.17
2/26/2019 7:42:35 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q3 19 Estimate To -0.08 From 0.12
2/26/2019 7:42:19 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q2 19 Estimate To -0.13 From 0.10
2/26/2019 7:42:05 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q1 19 Estimate To -0.23 From 0.03
2/26/2019 7:41:26 AM Wedbush Reiterates Biomarin Pharmaceutical Inc. (BMRN) At Outperform With $127 Price Target
2/21/2019 4:07:16 PM BioMarin Q4 GAAP Loss Per Share $0.03 Vs Loss $0.30 Prior Year
2/7/2019 9:27:41 AM Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) FY19 Rev. Estimate To 1738 M From 1706 M
2/7/2019 9:27:31 AM Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) FY18 Rev. Estimate To 1492 M From 1501 M
2/7/2019 9:27:19 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q4 18 Rev. Estimate To 354.9 M From 363.8 M
2/7/2019 9:26:52 AM Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) FY19 Estimate To 0.41 From 0.27
2/7/2019 9:26:00 AM Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) FY18 Estimate To -0.60 From -0.63
2/7/2019 9:25:46 AM Wedbush Is Increasing Biomarin Pharmaceutical Inc. (BMRN) Q4 18 Estimate To -0.19 From -0.21
2/7/2019 9:25:16 AM Wedbush Reiterates Biomarin Pharmaceutical Inc. (BMRN) At Outperform With $127 Price Target